Application Nr Approved Date Route Status External Links
ANDA210612 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Estradiol And Norethindrone Acetate Tablets Are An Estrogen And Progestin Combinations Indicated In A Woman With A Uterus For: Estradiol And Norethindrone Acetate Tablets 1 Mg/0.5 Mg And 0.5 Mg/0.1 Mg Are Indicated In A Woman With A Uterus For: Treatment Of Moderate To Severe Vasomotor Symptoms Due To Menopause ( 1.1 ) Prevention Of Postmenopausal Osteoporosis ( 1.3 ) Estradiol And Norethindrone Acetate Tablets 1 Mg/0.5 Mg Are Also Indicated In A Woman With A Uterus For: Treatment Of Moderate To Severe Symptoms Of Vulvar And Vaginal Atrophy Due To Menopause ( 1.2 ) 1.1 Treatment Of Moderate To Severe Vasomotor Symptoms Due To Menopause 1.2 Treatment Of Moderate To Severe Symptoms Of Vulvar And Vaginal Atrophy Due To Menopause Limitation Of Use When Prescribing Solely For The Treatment Of Moderate To Severe Symptoms Of Vulvar And Vaginal Atrophy Due To Menopause, Topical Vaginal Products Should Be Considered. 1.3 Prevention Of Postmenopausal Osteoporosis Limitation Of Use When Prescribing Solely For The Prevention Of Postmenopausal Osteoporosis, Therapy Should Only Be Considered For Women At Significant Risk Of Osteoporosis And Non-Estrogen Medication Should Be Carefully Considered.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Name Structure ZINC ID(s)
1. Estradiol ESTRADIOL ZINC3881556
2. Norethindrone Acetate

Comments